Eli Lilly strikes deal to buy Crispr gene-editing biotech Verve

World’s biggest drugmaker clinches $1.3bn deal as it hunts for experimental treatments to boost its pipeline

Jun 17, 2025 - 13:45
 0
Eli Lilly strikes deal to buy Crispr gene-editing biotech Verve
World’s biggest drugmaker clinches $1.3bn deal as it hunts for experimental treatments to boost its pipeline